CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
Clinical trial NCT00943488 · COMPLETED
Trial details
- NCT number
- NCT00943488
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-03-01
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.